A combined DHA-rich fish oil and cocoa flavanols intervention does not improve cognition or brain structure in older adults with memory complaints: results from the CANN randomized, controlled parallel-design study
The American Journal of Clinical Nutrition · 2023-08 · 118 (2) · 369-381
DOI: 10.1016/j.ajcnut.2023.06.008 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The American Journal of Clinical Nutrition, 2023-08. Verfasst von David Vauzour und 13 weiteren Autor:innen. Beteiligte Einrichtung: Norwich Medical School, University of East Anglia (UEA), Norwich, United Kingdom. Electronic address: D.Vauzour@uea.ac.uk. Hauptthemen laut MEDLINE: Chocolate, Fatty Acids, Omega-3. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Illinois Urbana-Champaign, University of Illinois System, Abbott Nutrition.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
BACKGROUND: There is evidence that both omega-3 long-chain polyunsaturated fatty acids (PUFAs) (eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) and cocoa flavanols can improve cognitive performance in both healthy individuals and in those with memory complaints. However, their combined effect is unknown. OBJECTIVES: To investigate the combined effect of EPA/DHA and cocoa flavanols (OM3FLAV) on cognitive performance and brain structures in older adults with memory complaints. METHODS: A randomized placebo-controlled trial of DHA-rich fish oil (providing 1.1 g/d DHA and 0.4 g/d EPA) and a flavanol-rich dark chocolate (providing 500 mg/d flavan-3-ols) was conducted in 259 older adults with either subjective cognitive impairment or mild cognitive impairment. Participants underwent assessment at baseline, 3 mo, and 12 mo. The primary outcome was the number of false-positives on a picture recognition task from the Cognitive Drug Research computerized assessment battery. Secondary outcomes included other cognition and mood outcomes, plasma lipids, brain-derived neurotrophic factor (BDNF), and glucose levels. A subset of 110 participants underwent structural neuroimaging at baseline and at 12 mo. RESULTS: 197 participants completed the study. The combined intervention had no significant effect on any cognitive outcomes, with the exception of reaction time variability (P = 0.007), alertness (P < 0.001), and executive function (P < 0.001), with a decline in function observed in the OM3FLAV group (118.6 [SD 25.3] at baseline versus 113.3 [SD 25.4] at 12 mo for executive function) relative to the control, and an associated decrease in cortical volume (P = 0.039). Compared with the control group, OM3FLAV increased plasma HDL, total cholesterol ratio (P < 0.001), and glucose (P = 0.008) and reduced TG concentrations (P < 0.001) by 3 mo, which were sustained to 12 mo, with no effect on BDNF. Changes in plasma EPA and DHA and urinary flavonoid metabolite concentrations confirmed compliance to the intervention. CONCLUSIONS: These results suggest that cosupplementation with ω-3 PUFAs and cocoa flavanols for 12 mo does not improve cognitive outcomes in those with cognitive impairment. This trial was registered at clinicaltrials.gov as NCT02525198.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Norwich Medical School, University of East Anglia (UEA), Norwich, United Kingdom. Electronic address: D.Vauzour@uea.ac.uk.
- Centre for Human Psychopharmacology, Swinburne University, Australia. Electronic address: andrew@scholeylab.com.
- Centre for Human Psychopharmacology, Swinburne University, Australia.
- Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign, Urbana, IL, United States.
- Norwich Medical School, University of East Anglia (UEA), Norwich, United Kingdom; Institute for Global Food Security, Queen's University Belfast, Belfast, Northern Ireland.
- Norwich Medical School, University of East Anglia (UEA), Norwich, United Kingdom.
Förderung
- University of Illinois Urbana-Champaign
- University of Illinois System
- Abbott Nutrition
Zitieren
APA
Vauzour, D., Scholey, A., White, D. J., Cohen, N. J., Cassidy, A., Gillings, R., Irvine, M. A., Kay, C. D., Kim, M., King, R., Legido-Quigley, C., Potter, J. F., Schwarb, H., & Minihane, A. M. (2023). A combined DHA-rich fish oil and cocoa flavanols intervention does not improve cognition or brain structure in older adults with memory complaints: results from the CANN randomized, controlled parallel-design study. The American Journal of Clinical Nutrition, 118(2), 369-381. https://doi.org/10.1016/j.ajcnut.2023.06.008
Vancouver
Vauzour D, Scholey A, White DJ, Cohen NJ, Cassidy A, Gillings R, et al. A combined DHA-rich fish oil and cocoa flavanols intervention does not improve cognition or brain structure in older adults with memory complaints: results from the CANN randomized, controlled parallel-design study. The American Journal of Clinical Nutrition. 2023;118(2):369-381. doi:10.1016/j.ajcnut.2023.06.008
BibTeX
@article{Vauzour2023,
author = {Vauzour, David and Scholey, Andrew and White, David J and Cohen, Neal J and Cassidy, Aedín and Gillings, Rachel and Irvine, Michael A and Kay, Colin D and Kim, Min and King, Rebecca and Legido-Quigley, Cristina and Potter, John F and Schwarb, Hilary and Minihane, Anne-Marie},
title = {A combined DHA-rich fish oil and cocoa flavanols intervention does not improve cognition or brain structure in older adults with memory complaints: results from the CANN randomized, controlled parallel-design study},
journal = {The American Journal of Clinical Nutrition},
year = {2023},
volume = {118},
number = {2},
pages = {369--381},
doi = {10.1016/j.ajcnut.2023.06.008}
}
EUVIMED